Position Profile:  Director of Health Outcomes

Department:  Marketing

General Purpose:  Develop and implement the strategy to substantiate Salient’s clinical and economic value proposition with evidence. Lead cross-functional effort to prioritize and execute clinical research program in support of company’s overall commercial objectives.

Reports to:  Vice President Marketing

Salient Surgical Technologies, Inc. is a 220+ person rapidly growing medical technology company that develops and markets innovative Advanced Energy surgical products based on our proprietary Transcollation™ technology to improve patient outcomes in a wide range of surgical procedures. Our Transcollation™ technology transforms collagen at the molecular level, which when applied to blood vessels, creates a permanent mechanical seal.   This permanent seal 1) improves surgeons’ visualization – a key to MIS surgery; 2) significantly improves patients’ post-operative hemoglobin levels which in turn speeds recovery and reduces the need for blood transfusions. 

Over 300,000 patients have been treated with our devices to improve post-op hemoglobin levels and reduce blood loss in surgical oncology, orthopaedic reconstruction (hip and knee replacements) and instrumented spine procedures (fusions).   

Salient Surgical has focused on building strong future earnings power by: 

Developing advanced energy products that deliver high clinical and economic value, receiving 510(k) clearances with broad indications for use which permit us to quickly move into new market applications without facing additional regulatory hurdles, investing in post marketing studies that document the clinical and economic benefits of our products in a variety of surgical settings (for example, our studies demonstrate a greater than 70% reduction in blood transfusions for patients receiving a primary hip replacement), building a deep intellectual property portfolio (At present we have a total of 80+ patents either issued or filed), building a sales force selling a surgeon preference product and identifying new applications and product opportunities that leverage our core technology.

The company is well-capitalized and key investors to date include Medtronic, Arnerich Massena, RiverVest, Piper Jaffray, Vanguard Ventures, Crescendo, Memphis Biomed Ventures and QuestMark Partners.

To support our continued growth and expansion, we have a deep team of veteran medical device executives from companies such as Biogen IDEC, Covidien, Hewlett Packard, Johnson & Johnson, and Smith + Nephew.  The team has deep experience driving rapid growth with new technology, and has in turn built teams of high talent, high performance people throughout the organization.

In addition, the Company has a group of seasoned industry executives on its board of directors from companies such as:  Aspect Medical, Haemonetics, Medtronic, Target Therapeutics, Innovasive Devices and TranS1 Spine.

 Our principal offices are located on the scenic New Hampshire seacoast, 50 minutes north of Boston.  The area is home to the University of New Hampshire and Phillips Exeter Academy as well as leading companies such as Fisher Scientific, Timberland, Lindt Chocolate USA and Liberty Mutual Insurance. The local Oyster River and Exeter school districts consistently rank at the top of New Hampshire’s school districts.  New Hampshire boasts no state income tax, capital gains tax or sales tax, making it one of the most business and family friendly states in the U.S.  For more information please visit our website at www.Salientsurgical.com or contact Don Cummings, Director Talent Acquisition, at don.cummings@salientsurgical.com

Responsibilities:

·         Formulate a research strategy to document the clinical benefits of Transcollation technology on patient outcomes and the resulting economic benefits to key stakeholders in the healthcare system

·         Define and implement clinical and economic study design plans, including protocol development, CRF content, and statistical analysis consistent with desired marketing claims and clinical endpoints

·         Set clinical trial milestones and timelines for upper management in line with corporate and departmental objectives

·         Develop credible relationships with key opinion leaders, medical directors, and regulatory officials

·         Develop relationships with prospective and existing clinical investigators and their staffs

·         Identify and select clinical evaluation sites

·         Negotiate and manage contracts with principal investigators and outside CRO’s and vendors

·         Prepare publication strategy for newly-generated clinical evidence

·         Manage resources, budgets, and priorities across clinical trials for multiple projects, making sure studies are completed on time and on budget

·         Review medical and regulatory literature, speak with medical and regulatory consultants and attend medical and regulatory meetings to track competing and complementary developments

·         Review clinical compliance assessments of audit findings and approve appropriate reports and monitors management following activities

·         Maintain accurate and timely sponsor/site correspondence and communication

·         Prepare and present project progress reports to keep company management informed

·         Assist in preparation of the clinical sections of regulatory submissions and international registration packages

·         Participate in Health Care Compliance Audits as needed

Desired Qualifications:

·         7+ years of architecting and implementing studies that validate a medical technology’s clinical and economic value

·         Proven track record of positively impacting revenue and market share through the use of said studies

·         Knowledge of medical device clinical affairs principles, practices, and methods

·         Dynamic communicator, orally and in writing

·         Possessing an established network and relationships with surgeons, nurses and medical professionals, ideally in orthopedics

·         Graduate Degree and appropriate certification in management of clinical trials

Personal Characteristics:

An attractive base salary combined with a performance bonus tied to objectives achieved. This position participates in our pre-IPO stock compensation plan as well.  A complete benefit package consisting of life, medical, dental and disability insurance is available, as well as a 401K and a flexible medical spending account (125 plan).

Salient Surgical Technologies is an equal opportunity employer